We are live on ! Find out more
IRMD icon

iRadimed

112 hedge funds and large institutions have $293M invested in iRadimed in 2023 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 36 increasing their positions, 30 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

383% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 6

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

29% more capital invested

Capital invested by funds: $227M → $293M (+$65.5M)

26% more funds holding

Funds holding: 89112 (+23)

20% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 30

2.86% more ownership

Funds ownership: 45.85%48.71% (+2.9%)

Holders
112
Holders Change
+23
Holders Change %
+25.84%
% of All Funds
1.76%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
29
Increased
36
Reduced
30
Closed
6
Calls
$5K
Puts
Net Calls
+$5K
Net Calls Change
+$5K
Name Holding Trade Value Shares
Change
Change in
Stake
Calamos Advisors
26
Calamos Advisors
Illinois
$1.57M +$77.9K +1,728 +6%
Two Sigma Investments
27
Two Sigma Investments
New York
$1.41M +$776K +17,205 +140%
Fiera Capital (Canada)
28
Fiera Capital (Canada)
Quebec, Canada
$1.35M -$75.8K -1,680 -6%
N
29
Nuveen
North Carolina
$1.29M +$569K +12,623 +87%
PAM
30
Panagora Asset Management
Massachusetts
$1.25M -$908K -20,128 -43%
Two Sigma Advisers
31
Two Sigma Advisers
New York
$1.2M +$401K +8,900 +55%
CIC
32
Cornercap Investment Counsel
Georgia
$1.19M -$546K -12,118 -33%
Janus Henderson Group
33
Janus Henderson Group
United Kingdom
$999K +$345K +7,658 +58%
Man Group
34
Man Group
United Kingdom
$985K +$930K +20,629 New
Charles Schwab
35
Charles Schwab
California
$953K +$27.6K +613 +3%
AR
36
Advisory Research
Illinois
$882K +$833K +18,474 New
Allspring Global Investments
37
Allspring Global Investments
North Carolina
$846K +$765K +16,967 +2,230%
CIA
38
Capital Impact Advisors
Massachusetts
$841K -$79.9K -1,771 -9%
Prudential Financial
39
Prudential Financial
New Jersey
$831K -$266K -5,900 -25%
LSV Asset Management
40
LSV Asset Management
Illinois
$831K
CAM
41
ClariVest Asset Management
California
$800K +$134K +2,981 +22%
Tudor Investment Corp
42
Tudor Investment Corp
Connecticut
$750K +$307K +6,817 +77%
UBS Group
43
UBS Group
Switzerland
$718K +$332K +7,370 +96%
JP Morgan Chase
44
JP Morgan Chase
New York
$694K +$256K +5,686 +64%
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$635K +$308K +6,819 +105%
Jacobs Levy Equity Management
46
Jacobs Levy Equity Management
New Jersey
$624K +$589K +13,068 New
AllianceBernstein
47
AllianceBernstein
Tennessee
$620K -$14K -310 -2%
Ameriprise
48
Ameriprise
Minnesota
$580K -$364K -8,072 -40%
SO
49
STRS Ohio
Ohio
$563K -$81.2K -1,800 -13%
BNP Paribas Financial Markets
50
BNP Paribas Financial Markets
France
$519K +$151K +3,340 +44%

IRMD Hedge Fund Activity: Q2 2023 in Review

112 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q2 2023, worth a combined $293M — up 29% from $227M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new IRMD positions and 6 closed out — a net gain of 23 holders — while 36 added to existing stakes and 30 trimmed.

The largest buyer was Resource Consulting Group, opening a new position worth an estimated $5.77M. The largest seller was RK Capital Management (Colorado), cutting an estimated $2.13M.

  • 112 institutional investors held iRadimed (IRMD) as of Q2 2023, up from 89 in Q1 2023.
  • Funds reported $293M of iRadimed stock for Q2 2023, up 29% quarter-over-quarter.
  • 29 funds opened new iRadimed positions in Q2 2023 and 6 closed out, a net change of +23 holders.
  • The largest iRadimed buyer in Q2 2023 was Resource Consulting Group, an estimated $5.77M added.
  • The largest iRadimed seller in Q2 2023 was RK Capital Management (Colorado), an estimated $2.13M sold.

Based on aggregated 13F filings for Q2 2023.